(TIPS) Targeting Platelet Activation, Platelet-Leukocyte Aggregates, and Acute Lung Injury In Pneumonia with Ticagrelor

Grants and Contracts Details

StatusFinished
Effective start/end date4/23/134/12/17

Funding

  • AstraZeneca Pharmaceuticals AB: $639,376.00